MOREPENLAB — Morepen Laboratories Cashflow Statement
0.000.00%
- IN₹31.66bn
- IN₹31.85bn
- IN₹18.12bn
- 72
- 26
- 55
- 51
Annual cashflow statement for Morepen Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 985 | 1,267 | 558 | 1,354 | 1,551 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 16.8 | -81.8 | -0.257 | 7.28 | 88.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -796 | -2,064 | -1,748 | -962 | -1,608 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 508 | -578 | -912 | 734 | 321 |
Capital Expenditures | -404 | -674 | -460 | -813 | -2,142 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -300 | 357 | -5.37 | -19.6 | -1,073 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Cash from Investing Activities | -704 | -317 | -465 | -833 | -3,215 |
Financing Cash Flow Items | -0.548 | 98.3 | -2.04 | 13.7 | 331 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 473 | 639 | 1,435 | 52 | 2,999 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 277 | -256 | 58.6 | -47.2 | 104 |